Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Yigal Nochomovitz is an analyst at Citigroup. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/07/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/03/2024 | ARDX | Buy Now | Ardelyx | $5.46 | 83.15% | $14 → $10 | Maintains | Buy | Get Alert |
| 06/26/2024 | MRUS | Buy Now | Merus | $55.71 | 66.94% | $70 → $93 | Maintains | Buy | Get Alert |
| 06/18/2024 | OVID | Buy Now | Ovid Therapeutics | $0.83 | 45.4% | $3.5 → $1.2 | Maintains | Neutral | Get Alert |
| 06/17/2024 | STTK | Buy Now | Shattuck Labs | $3.55 | 153.52% | $10 → $9 | Maintains | Buy | Get Alert |
| 06/07/2024 | BMEA | Buy Now | Biomea Fusion | $4.80 | 837.5% | $90 → $45 | Maintains | Buy | Get Alert |
| 06/03/2024 | RCUS | Buy Now | Arcus Biosciences | $13.84 | 174.57% | $36 → $38 | Maintains | Buy | Get Alert |
| 05/31/2024 | SMMT | Buy Now | Summit Therapeutics | $7.50 | 73.33% | $7 → $13 | Maintains | Buy | Get Alert |
| 05/31/2024 | CALT | Buy Now | Calliditas Therapeutics | $39.08 | -0.2% | → $39 | Downgrade | Buy → Neutral | Get Alert |
| 05/23/2024 | CRSP | Buy Now | CRISPR Therapeutics | $53.23 | 57.81% | $89 → $84 | Maintains | Buy | Get Alert |
| 05/09/2024 | SNDX | Buy Now | Syndax Pharmaceuticals | $21.49 | 39.6% | $32 → $30 | Maintains | Buy | Get Alert |
| 05/08/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $37.11 | 61.68% | $67 → $60 | Maintains | Buy | Get Alert |
| 05/07/2024 | OVID | Buy Now | Ovid Therapeutics | $0.83 | 324.09% | $4 → $3.5 | Maintains | Neutral | Get Alert |
| 05/07/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $8.50 | 64.71% | $15 → $14 | Maintains | Buy | Get Alert |
| 05/07/2024 | SMMT | Buy Now | Summit Therapeutics | $7.50 | -6.67% | → $7 | Initiates | → Buy | Get Alert |
| 05/03/2024 | ZYME | Buy Now | Zymeworks | $8.94 | 78.97% | $17 → $16 | Maintains | Buy | Get Alert |
| 05/03/2024 | ARDX | Buy Now | Ardelyx | $5.46 | 156.41% | $13 → $14 | Maintains | Buy | Get Alert |
| 04/18/2024 | CRSP | Buy Now | CRISPR Therapeutics | $53.23 | 67.2% | $88 → $89 | Maintains | Buy | Get Alert |
| 04/18/2024 | PRQR | Buy Now | ProQR Therapeutics | $1.74 | 14.94% | $1.8 → $2 | Maintains | Neutral | Get Alert |
| 04/10/2024 | LENZ | Buy Now | LENZ Therapeutics | $18.38 | 84.98% | → $34 | Initiates | → Buy | Get Alert |
| 03/21/2024 | IDYA | Buy Now | IDEAYA Biosciences | $39.67 | 51.25% | $40 → $60 | Maintains | Buy | Get Alert |
| 03/11/2024 | MGNX | Buy Now | Macrogenics | $4.23 | 491.02% | $13 → $25 | Maintains | Buy | Get Alert |
| 03/07/2024 | RIGL | Buy Now | Rigel Pharmaceuticals | $7.87 | -49.17% | $30 → $40 | Maintains | Buy | Get Alert |
| 02/29/2024 | ZLAB | Buy Now | Zai Lab | $16.97 | 288.92% | $123 → $66 | Maintains | Buy | Get Alert |
| 02/27/2024 | KRYS | Buy Now | Krystal Biotech | $191.29 | 1.94% | $160 → $195 | Maintains | Buy | Get Alert |
| 02/26/2024 | HARP | Buy Now | Harpoon Therapeutics | — | — | $13 → $23 | Downgrade | Buy → Neutral | Get Alert |
| 02/20/2024 | AVBP | Buy Now | ArriVent BioPharma | $18.66 | 60.77% | → $30 | Initiates | → Buy | Get Alert |
| 02/16/2024 | APLT | Buy Now | Applied Therapeutics | $4.86 | 44.03% | $5 → $7 | Maintains | Buy | Get Alert |
| 02/15/2024 | ARVN | Buy Now | Arvinas | $25.68 | 114.17% | $36 → $55 | Downgrade | Buy → Neutral | Get Alert |
| 02/14/2024 | ARVN | Buy Now | Arvinas | $25.68 | 114.17% | $36 → $55 | Downgrade | Buy → Neutral | Get Alert |
| 02/08/2024 | ARCT | Buy Now | Arcturus Therapeutics | $21.57 | 122.53% | $40 → $48 | Maintains | Buy | Get Alert |
| 01/30/2024 | OLMA | Buy Now | Olema Pharmaceuticals | $11.02 | 81.49% | → $20 | Initiates | → Buy | Get Alert |
| 01/10/2024 | ARDX | Buy Now | Ardelyx | $5.46 | 156.41% | $9 → $14 | Maintains | Buy | Get Alert |
| 12/20/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | $48 → $59 | Downgrade | Buy → Neutral | Get Alert |
| 12/20/2023 | MGNX | Buy Now | Macrogenics | $4.23 | 207.33% | $7 → $13 | Upgrade | Neutral → Buy | Get Alert |
| 12/15/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $37.11 | 80.54% | $70 → $67 | Maintains | Buy | Get Alert |
| 12/08/2023 | BMEA | Buy Now | Biomea Fusion | $4.80 | 1775% | → $90 | Reiterates | Buy → Buy | Get Alert |
| 10/26/2023 | ZLAB | Buy Now | Zai Lab | $16.97 | 654.27% | $130 → $128 | Maintains | Buy | Get Alert |
| 10/26/2023 | BGNE | Buy Now | BeiGene | $144.35 | 97.44% | $290 → $285 | Maintains | Buy | Get Alert |
| 10/24/2023 | ARVN | Buy Now | Arvinas | $25.68 | 40.19% | $72 → $36 | Maintains | Buy | Get Alert |
| 10/24/2023 | HARP | Buy Now | Harpoon Therapeutics | — | — | $33 → $13 | Maintains | Buy | Get Alert |
| 10/17/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $3.31 | 141.69% | $25 → $8 | Maintains | Buy | Get Alert |
| 10/06/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $37.11 | 88.63% | $54 → $70 | Maintains | Buy | Get Alert |
| 09/21/2023 | BGNE | Buy Now | BeiGene | $144.35 | 100.9% | $285 → $290 | Maintains | Buy | Get Alert |
| 09/18/2023 | PRQR | Buy Now | ProQR Therapeutics | $1.74 | 3.45% | $2.1 → $1.8 | Maintains | Neutral | Get Alert |
| 09/18/2023 | RAIN | Buy Now | Rain Oncology | — | — | $1.5 → $1 | Maintains | Neutral | Get Alert |
| 09/18/2023 | HARP | Buy Now | Harpoon Therapeutics | — | — | $60 → $33 | Maintains | Buy | Get Alert |
| 08/30/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $37.11 | 45.51% | $45 → $54 | Maintains | Buy | Get Alert |
| 08/29/2023 | EIGR | Buy Now | Eiger BioPharmaceuticals | — | — | $120 → $90 | Maintains | Buy | Get Alert |
| 08/29/2023 | GRCL | Buy Now | Gracell Biotechnologies | — | — | $12 → $11 | Maintains | Buy | Get Alert |
| 08/29/2023 | GRTX | Buy Now | Galera Therapeutics | $0.13 | 91.86% | $0.4 → $0.25 | Maintains | Neutral | Get Alert |
| 08/24/2023 | RCUS | Buy Now | Arcus Biosciences | $13.84 | 217.92% | $41 → $44 | Maintains | Buy | Get Alert |
| 08/21/2023 | ATRA | Buy Now | Atara Biotherapeutics | $7.50 | -81.33% | $50 → $35 | Maintains | Sell | Get Alert |
| 08/21/2023 | ARVN | Buy Now | Arvinas | $25.68 | 180.37% | $77 → $72 | Maintains | Buy | Get Alert |
| 08/18/2023 | CRSP | Buy Now | CRISPR Therapeutics | $53.23 | 31.5% | → $70 | Upgrade | Neutral → Buy | Get Alert |
| 08/17/2023 | CRSP | Buy Now | CRISPR Therapeutics | $53.23 | 31.5% | → $70 | Upgrade | Neutral → Buy | Get Alert |
| 08/10/2023 | MRUS | Buy Now | Merus | $55.71 | -17.43% | $48 → $46 | Maintains | Buy | Get Alert |
| 08/10/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | $51 → $48 | Upgrade | Neutral → Buy | Get Alert |
| 08/01/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $127 → $172.5 | Downgrade | Buy → Neutral | Get Alert |
| 07/26/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $21.49 | 62.87% | $31 → $35 | Maintains | Buy | Get Alert |
| 07/21/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $37.11 | 115.58% | $106 → $80 | Maintains | Buy | Get Alert |
| 07/20/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $37.11 | 115.58% | $106 → $80 | Maintains | Buy | Get Alert |
| 07/17/2023 | BGNE | Buy Now | BeiGene | $144.35 | 90.51% | → $275 | Initiates | → Buy | Get Alert |
| 06/26/2023 | BMEA | Buy Now | Biomea Fusion | $4.80 | 1775% | $53 → $90 | Maintains | Buy | Get Alert |
| 06/07/2023 | RARE | Buy Now | Ultragenyx Pharmaceutical | $41.49 | 220.56% | $130 → $133 | Maintains | Buy | Get Alert |
| 06/01/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $3.31 | 655.29% | $28 → $25 | Maintains | Buy | Get Alert |
| 05/31/2023 | LXRX | Buy Now | Lexicon Pharmaceuticals | $1.61 | 396.89% | $6 → $8 | Maintains | Buy | Get Alert |
| 05/26/2023 | PRQR | Buy Now | ProQR Therapeutics | $1.74 | 20.69% | $2.25 → $2.1 | Maintains | Neutral | Get Alert |
| 05/26/2023 | RCUS | Buy Now | Arcus Biosciences | $13.84 | 196.24% | $40 → $41 | Maintains | Buy | Get Alert |
| 05/26/2023 | UBX | Buy Now | Unity Biotechnology | $1.34 | 347.76% | $5 → $6 | Maintains | Buy | Get Alert |
| 05/23/2023 | RAIN | Buy Now | Rain Oncology | — | — | $24 → $1.5 | Downgrade | Buy → Neutral | Get Alert |
| 05/23/2023 | CRSP | Buy Now | CRISPR Therapeutics | $53.23 | 31.5% | $55 → $70 | Maintains | Neutral | Get Alert |
| 05/18/2023 | BMEA | Buy Now | Biomea Fusion | $4.80 | 1004.17% | $55 → $53 | Maintains | Buy | Get Alert |
| 05/18/2023 | MRUS | Buy Now | Merus | $55.71 | -13.84% | $47 → $48 | Maintains | Buy | Get Alert |
| 05/18/2023 | ZYME | Buy Now | Zymeworks | $8.94 | 101.34% | $17 → $18 | Maintains | Buy | Get Alert |
| 05/11/2023 | ZLAB | Buy Now | Zai Lab | $16.97 | 666.06% | $138 → $130 | Maintains | Buy | Get Alert |
| 05/11/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | $53 → $51 | Maintains | Neutral | Get Alert |
| 05/10/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $21.49 | 44.25% | $32 → $31 | Maintains | Buy | Get Alert |
| 05/08/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $37.11 | 185.64% | $88 → $106 | Maintains | Buy | Get Alert |
| 05/05/2023 | RARE | Buy Now | Ultragenyx Pharmaceutical | $41.49 | 213.33% | $130 → $130 | Maintains | Buy | Get Alert |
| 04/17/2023 | MRUS | Buy Now | Merus | $55.71 | -15.63% | $38 → $47 | Maintains | Buy | Get Alert |
| 04/07/2023 | BMEA | Buy Now | Biomea Fusion | $4.80 | 1045.83% | $60 → $55 | Maintains | Buy | Get Alert |
| 04/05/2023 | MRUS | Buy Now | Merus | $55.71 | -31.79% | $30 → $38 | Maintains | Buy | Get Alert |
| 04/05/2023 | ORIC | Buy Now | ORIC Pharmaceuticals | $8.50 | -5.88% | $9 → $8 | Maintains | Buy | Get Alert |
| 04/05/2023 | APLT | Buy Now | Applied Therapeutics | $4.86 | 2.88% | $23 → $5 | Maintains | Buy | Get Alert |
| 04/05/2023 | CLLS | Buy Now | Cellectis | $2.05 | 680.49% | $24 → $16 | Maintains | Buy | Get Alert |
| 03/29/2023 | BMEA | Buy Now | Biomea Fusion | $4.80 | 1150% | $20 → $60 | Maintains | Buy | Get Alert |
| 03/28/2023 | UBX | Buy Now | Unity Biotechnology | $1.34 | 273.13% | $15 → $5 | Maintains | Buy | Get Alert |
| 03/18/2023 | RARE | Buy Now | Ultragenyx Pharmaceutical | $41.49 | 213.33% | $135 → $130 | Maintains | Buy | Get Alert |
| 03/18/2023 | CRSP | Buy Now | CRISPR Therapeutics | $53.23 | 3.33% | $63 → $55 | Maintains | Neutral | Get Alert |
| 03/10/2023 | ZYME | Buy Now | Zymeworks | $8.94 | 90.16% | $21 → $17 | Maintains | Buy | Get Alert |
| 03/10/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $3.31 | 745.92% | $23 → $28 | Maintains | Buy | Get Alert |
| 03/09/2023 | RIGL | Buy Now | Rigel Pharmaceuticals | $7.87 | -61.88% | $20 → $30 | Maintains | Buy | Get Alert |
| 03/08/2023 | RCUS | Buy Now | Arcus Biosciences | $13.84 | 189.02% | $42 → $40 | Maintains | Buy | Get Alert |
| 03/02/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $21.49 | 48.91% | $29 → $32 | Maintains | Buy | Get Alert |
| 03/02/2023 | FATE | Buy Now | Fate Therapeutics | $3.10 | 222.58% | $9 → $10 | Maintains | Buy | Get Alert |
| 03/01/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $53 → $120 | Maintains | Buy | Get Alert |
| 02/24/2023 | BMEA | Buy Now | Biomea Fusion | $4.80 | 316.67% | → $20 | Initiates | → Buy | Get Alert |
| 02/24/2023 | CALT | Buy Now | Calliditas Therapeutics | $39.08 | 102.15% | $76 → $79 | Maintains | Buy | Get Alert |
| 02/21/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $37.11 | 145.22% | $86 → $91 | Maintains | Buy | Get Alert |
| 01/09/2023 | RARE | Buy Now | Ultragenyx Pharmaceutical | $41.49 | 225.38% | $138 → $135 | Maintains | Buy | Get Alert |
| 12/30/2022 | ARDX | Buy Now | Ardelyx | $5.46 | 28.21% | $6 → $7 | Maintains | Buy | Get Alert |
| 12/20/2022 | RCUS | Buy Now | Arcus Biosciences | $13.84 | 203.47% | $37 → $42 | Maintains | Buy | Get Alert |
| 12/09/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | $121 → $53 | Downgrade | Buy → Neutral | Get Alert |
| 12/05/2022 | ARVN | Buy Now | Arvinas | $25.68 | 180.37% | $88 → $72 | Maintains | Buy | Get Alert |
| 12/02/2022 | RIGL | Buy Now | Rigel Pharmaceuticals | $7.87 | — | — | Upgrade | Neutral → Buy | Get Alert |
| 11/23/2022 | CRSP | Buy Now | CRISPR Therapeutics | $53.23 | 18.35% | $83 → $63 | Maintains | Neutral | Get Alert |
| 11/23/2022 | RCUS | Buy Now | Arcus Biosciences | $13.84 | 167.34% | $40 → $37 | Maintains | Buy | Get Alert |
| 11/23/2022 | RAIN | Buy Now | Rain Oncology | — | — | $30 → $29 | Maintains | Buy | Get Alert |
| 11/23/2022 | MGNX | Buy Now | Macrogenics | $4.23 | 65.48% | $16 → $7 | Downgrade | Buy → Neutral | Get Alert |
| 11/22/2022 | LXRX | Buy Now | Lexicon Pharmaceuticals | $1.61 | 272.67% | $16 → $6 | Maintains | Buy | Get Alert |
| 11/21/2022 | ALDX | Buy Now | Aldeyra Therapeutics | $3.31 | 594.86% | $26 → $23 | Maintains | Buy | Get Alert |
| 11/16/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | $127 → $121 | Maintains | Buy | Get Alert |
| 11/16/2022 | MRUS | Buy Now | Merus | $55.71 | -46.15% | $34 → $30 | Maintains | Buy | Get Alert |
| 11/16/2022 | FATE | Buy Now | Fate Therapeutics | $3.10 | 2480.65% | $87 → $80 | Maintains | Buy | Get Alert |
| 11/11/2022 | ZLAB | Buy Now | Zai Lab | $16.97 | 648.38% | $199 → $127 | Maintains | Buy | Get Alert |
| 11/09/2022 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $51 → $53 | Maintains | Buy | Get Alert |
| 11/03/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $41.49 | 232.61% | $142 → $138 | Maintains | Buy | Get Alert |
| 11/03/2022 | ARCT | Buy Now | Arcturus Therapeutics | $21.57 | — | — | Upgrade | Neutral → Buy | Get Alert |
| 10/27/2022 | IDYA | Buy Now | IDEAYA Biosciences | $39.67 | -34.46% | → $26 | Initiates | → Buy | Get Alert |
| 10/14/2022 | PROK | Buy Now | ProKidney | $2.19 | 630.59% | → $16 | Initiates | → Buy | Get Alert |
| 09/22/2022 | GRCL | Buy Now | Gracell Biotechnologies | — | — | → $12 | Initiates | → Buy | Get Alert |
| 09/16/2022 | OPT | Buy Now | Opthea | $1.95 | 2156.41% | $45 → $44 | Maintains | Buy | Get Alert |
| 09/16/2022 | IPHA | Buy Now | Innate Pharma | $2.14 | 460.75% | $16 → $12 | Maintains | Buy | Get Alert |
| 09/14/2022 | ZYME | Buy Now | Zymeworks | $8.94 | 134.9% | $27 → $21 | Maintains | Buy | Get Alert |
| 08/29/2022 | OVID | Buy Now | Ovid Therapeutics | $0.83 | 202.92% | $2.4 → $2.5 | Maintains | Neutral | Get Alert |
| 08/29/2022 | MGNX | Buy Now | Macrogenics | $4.23 | 278.25% | $13 → $16 | Maintains | Buy | Get Alert |
| 08/29/2022 | HARP | Buy Now | Harpoon Therapeutics | — | — | $70 → $60 | Maintains | Buy | Get Alert |
| 08/29/2022 | CRBU | Buy Now | Caribou Biosciences | $1.60 | 2275% | $39 → $38 | Maintains | Buy | Get Alert |
| 08/29/2022 | AERI | Buy Now | Aerie Pharmaceuticals | — | — | — | Downgrade | Buy → Neutral | Get Alert |
| 08/26/2022 | ZYME | Buy Now | Zymeworks | $8.94 | 202.01% | $28 → $27 | Maintains | Buy | Get Alert |
| 08/18/2022 | RCUS | Buy Now | Arcus Biosciences | $13.84 | 189.02% | $48 → $40 | Maintains | Buy | Get Alert |
| 08/17/2022 | MRUS | Buy Now | Merus | $55.71 | -38.97% | $37 → $34 | Maintains | Buy | Get Alert |
| 08/17/2022 | APLT | Buy Now | Applied Therapeutics | $4.86 | 373.25% | $29 → $23 | Maintains | Buy | Get Alert |
| 08/15/2022 | UBX | Buy Now | Unity Biotechnology | $1.34 | 497.01% | $50 → $80 | Maintains | Buy | Get Alert |
| 08/09/2022 | ZLAB | Buy Now | Zai Lab | $16.97 | 1072.66% | $193 → $199 | Maintains | Buy | Get Alert |
| 08/02/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $41.49 | 242.25% | $146 → $142 | Maintains | Buy | Get Alert |
| 08/02/2022 | CRSP | Buy Now | CRISPR Therapeutics | $53.23 | 55.93% | $53 → $83 | Maintains | Neutral | Get Alert |
| 07/20/2022 | APLS | Buy Now | Apellis Pharmaceuticals | $37.11 | 131.74% | $81 → $86 | Maintains | Buy | Get Alert |
| 07/20/2022 | ATRA | Buy Now | Atara Biotherapeutics | $7.50 | -60% | → $75 | Downgrade | Neutral → Sell | Get Alert |
| 07/07/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | $208 → $127 | Maintains | Buy | Get Alert |
| 07/01/2022 | LXRX | Buy Now | Lexicon Pharmaceuticals | $1.61 | 1142.24% | $18 → $20 | Maintains | Buy | Get Alert |
| 06/09/2022 | RIGL | Buy Now | Rigel Pharmaceuticals | $7.87 | -89.83% | $70 → $8 | Downgrade | Buy → Neutral | Get Alert |
| 06/09/2022 | ALDX | Buy Now | Aldeyra Therapeutics | $3.31 | 685.5% | $21 → $26 | Maintains | Buy | Get Alert |
| 06/01/2022 | STTK | Buy Now | Shattuck Labs | $3.55 | 266.2% | → $13 | Initiates | → Buy | Get Alert |
| 05/27/2022 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $43 → $46 | Maintains | Buy | Get Alert |
| 05/20/2022 | OVID | Buy Now | Ovid Therapeutics | $0.83 | 190.8% | $4 → $2.4 | Maintains | Neutral | Get Alert |
| 05/20/2022 | ORIC | Buy Now | ORIC Pharmaceuticals | $8.50 | 5.88% | $10 → $9 | Maintains | Buy | Get Alert |
| 05/20/2022 | ARVN | Buy Now | Arvinas | $25.68 | 301.09% | $113 → $103 | Maintains | Buy | Get Alert |
| 05/20/2022 | APLT | Buy Now | Applied Therapeutics | $4.86 | 496.71% | $30 → $29 | Maintains | Buy | Get Alert |
| 05/19/2022 | MRUS | Buy Now | Merus | $55.71 | -33.58% | $38 → $37 | Maintains | Buy | Get Alert |
| 05/17/2022 | UBX | Buy Now | Unity Biotechnology | $1.34 | 273.13% | $60 → $50 | Maintains | Buy | Get Alert |
| 05/17/2022 | CRSP | Buy Now | CRISPR Therapeutics | $53.23 | -0.43% | $64 → $53 | Maintains | Neutral | Get Alert |
| 05/13/2022 | CRBU | Buy Now | Caribou Biosciences | $1.60 | 2337.5% | $29 → $39 | Maintains | Buy | Get Alert |
| 05/12/2022 | ZLAB | Buy Now | Zai Lab | $16.97 | 1037.3% | $198 → $193 | Maintains | Buy | Get Alert |
| 05/10/2022 | ATRA | Buy Now | Atara Biotherapeutics | $7.50 | 6.67% | $575 → $200 | Downgrade | Buy → Neutral | Get Alert |
| 05/10/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $41.49 | 251.89% | $150 → $146 | Maintains | Buy | Get Alert |
| 05/09/2022 | ZYME | Buy Now | Zymeworks | $8.94 | 213.2% | $30 → $28 | Maintains | Buy | Get Alert |
| 05/09/2022 | ZYME | Buy Now | Zymeworks | $8.94 | 213.2% | $30 → $28 | Maintains | Buy | Get Alert |
| 05/05/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | $227 → $208 | Maintains | Buy | Get Alert |
| 03/16/2022 | HARP | Buy Now | Harpoon Therapeutics | — | — | $140 → $70 | Maintains | Buy | Get Alert |
| 03/15/2022 | CRSP | Buy Now | CRISPR Therapeutics | $53.23 | 20.23% | $90 → $64 | Maintains | Neutral | Get Alert |
| 03/15/2022 | ARCT | Buy Now | Arcturus Therapeutics | $21.57 | 298.7% | $114 → $86 | Maintains | Buy | Get Alert |
| 03/02/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | $244 → $227 | Maintains | Buy | Get Alert |
| 02/28/2022 | ZYME | Buy Now | Zymeworks | $8.94 | 235.57% | $53 → $30 | Maintains | Buy | Get Alert |
| 02/28/2022 | MGNX | Buy Now | Macrogenics | $4.23 | 396.45% | $23 → $21 | Upgrade | Neutral → Buy | Get Alert |
| 12/21/2021 | ALDX | Buy Now | Aldeyra Therapeutics | $3.31 | 534.44% | $25 → $21 | Maintains | Buy | Get Alert |
| 12/20/2021 | GRTX | Buy Now | Galera Therapeutics | $0.13 | 15249.19% | — | Maintains | Buy | Get Alert |
| 12/03/2021 | CRSP | Buy Now | CRISPR Therapeutics | $53.23 | 69.08% | $132 → $90 | Maintains | Neutral | Get Alert |
| 12/01/2021 | ARDX | Buy Now | Ardelyx | $5.46 | 138.1% | — | Maintains | Buy | Get Alert |
| 11/24/2021 | APLS | Buy Now | Apellis Pharmaceuticals | $37.11 | 94.02% | — | Maintains | Buy | Get Alert |
| 11/15/2021 | CRBU | Buy Now | Caribou Biosciences | $1.60 | 1587.5% | — | Upgrade | Neutral → Buy | Get Alert |
| 08/09/2021 | EIGR | Buy Now | Eiger BioPharmaceuticals | — | — | $780 → $810 | Maintains | Buy | Get Alert |
| 05/21/2021 | CRSP | Buy Now | CRISPR Therapeutics | $53.23 | 3.33% | $45 → $55 | Maintains | Sell | Get Alert |
| 04/28/2021 | ALDX | Buy Now | Aldeyra Therapeutics | $3.31 | 655.29% | $22 → $25 | Maintains | Buy | Get Alert |
| 03/12/2021 | ALDX | Buy Now | Aldeyra Therapeutics | $3.31 | 564.65% | $22 → $22 | Maintains | Buy | Get Alert |
| 12/07/2020 | CRSP | Buy Now | CRISPR Therapeutics | $53.23 | -15.46% | → $45 | Maintains | Sell | Get Alert |
| 08/06/2020 | RIGL | Buy Now | Rigel Pharmaceuticals | $7.87 | 1.65% | $70 → $80 | Maintains | Buy | Get Alert |
| 08/05/2020 | CRSP | Buy Now | CRISPR Therapeutics | $53.23 | -41.76% | $31 → $31 | Maintains | Sell | Get Alert |
| 06/26/2019 | EIGR | Buy Now | Eiger BioPharmaceuticals | — | — | → $660 | Initiates | → Buy | Get Alert |
| 08/27/2018 | RIGL | Buy Now | Rigel Pharmaceuticals | $7.87 | 8.01% | → $85 | Initiates | → Buy | Get Alert |
| 06/11/2018 | ATRA | Buy Now | Atara Biotherapeutics | $7.50 | 206.66% | $625 → $575 | Maintains | Sell | Get Alert |
| 08/22/2016 | ATRA | Buy Now | Atara Biotherapeutics | $7.50 | 6.67% | $250 → $200 | Maintains | Sell | Get Alert |
| 08/19/2016 | ATRA | Buy Now | Atara Biotherapeutics | $7.50 | 6.67% | $250 → $200 | Maintains | Sell | Get Alert |
| 12/15/2015 | ATRA | Buy Now | Atara Biotherapeutics | $7.50 | 113.33% | $1275 → $400 | Downgrade | Buy → Sell | Get Alert |
| 11/10/2014 | ATRA | Buy Now | Atara Biotherapeutics | $7.50 | 393.33% | → $925 | Initiates | → Buy | Get Alert |
| 03/06/2013 | RIGL | Buy Now | Rigel Pharmaceuticals | $7.87 | -11.05% | $60 → $70 | Maintains | Neutral | Get Alert |
| 12/13/2012 | RIGL | Buy Now | Rigel Pharmaceuticals | $7.87 | -23.76% | $140 → $60 | Downgrade | Buy → Neutral | Get Alert |
| 02/22/2012 | RIGL | Buy Now | Rigel Pharmaceuticals | $7.87 | 65.18% | → $130 | Upgrade | Neutral → Buy | Get Alert |
